Phio Pharmaceuticals Joins Renmark Virtual Non-Deal Roadshow

Bitget2026/10/19 13:54

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Phio Pharmaceuticals will participate in Renmark Financial Communications’ virtual non-deal roadshow on October 20, 2026, at noon EDT.
CEO Robert Bitterman will present the INTASYL siRNA platform, including lead candidate PH-762 for cutaneous carcinomas, followed by live Q&A.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610190953NEWSFILECNPR____20261019_319697_1) on October 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Phio Pharmaceuticals Joins Renmark Virtual Non-Deal Roadshow

You may also like

Crypto prices